首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 美國COPD(慢性阻塞性肺病)市場
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

美國COPD(慢性阻塞性肺病)市場

U.S. COPD Market - Therapeutic Overview and Patient Outlook

出版商 Frost & Sullivan
出版日期 2007年06月 商品編碼 52899
內容資訊 英文 80 Pages
價格
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


美國COPD(慢性阻塞性肺病)市場 是由出版商Frost & Sullivan在2007年06月所出版的。 這份英文市場調查報告書包含80 Pages 價格從美金6000起跳。

目錄

Abstract

This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary
    • Introduction

2 TOTAL MARKET

  • Research Scope and Methodology
    • Scope and Segmentation
    • Research Methodology
  • Disease Overview
    • Introduction
    • Disease Definition
    • Symptoms
    • Risk Factors
    • Diagnosis
    • Treatments
    • Drug Delivery Methods
    • Disease Statistics
    • Competitive Structure
  • Patient Outlook
    • Patient Forecasts
  • General Market Trends
    • Challenges
    • Strategic Recommendations for Challenges
    • Market Drivers
    • Market Restraints

3 MARKETED THERAPIES OVERVIEW

  • Overview
    • Bronchodilators
    • Anti-inflammatories
    • Combination Therapies
    • Novel Therapeutic Approaches

4 APPENDIX

  • Decision Support Databases
    • Chronic Obstructive Pulmonary Disease Population
    • Prevalence of Male Smokers
    • Prevalence of Female Smokers
    • Population 65 and Over
    • Prevalence of Asthma
Back to Top